|
|
Volumn 58, Issue 12, 1997, Pages 538-546
|
|
The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the North American trials
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIPERIDEN;
CHLORAL HYDRATE;
CLOZAPINE;
HALOPERIDOL;
NEUROLEPTIC AGENT;
OLANZAPINE;
PLACEBO;
PROCYCLIDINE;
QUETIAPINE;
RISPERIDONE;
RITANSERIN;
SERTINDOLE;
ZIPRASIDONE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
EXTRAPYRAMIDAL SYMPTOM;
FACTORIAL ANALYSIS;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MENTAL DISEASE;
MULTICENTER STUDY;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
PSYCHOSIS;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
|
|
EID: 0031431410
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: 10.4088/JCP.v58n1205 Document Type: Article |
|
Times cited : (694)
|
|
References (33)
|
